ATE108662T1 - ANTIMICROBIAL PEPTIDES, COMPOSITIONS CONTAINING SAME AND USES THEREOF. - Google Patents

ANTIMICROBIAL PEPTIDES, COMPOSITIONS CONTAINING SAME AND USES THEREOF.

Info

Publication number
ATE108662T1
ATE108662T1 AT89907461T AT89907461T ATE108662T1 AT E108662 T1 ATE108662 T1 AT E108662T1 AT 89907461 T AT89907461 T AT 89907461T AT 89907461 T AT89907461 T AT 89907461T AT E108662 T1 ATE108662 T1 AT E108662T1
Authority
AT
Austria
Prior art keywords
cys
val
arg
compositions containing
thr
Prior art date
Application number
AT89907461T
Other languages
German (de)
Inventor
Craig G Wilde
Joseph E Griffith
Marian N Marra
Randal W Scott
Original Assignee
Incyte Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharma Inc filed Critical Incyte Pharma Inc
Application granted granted Critical
Publication of ATE108662T1 publication Critical patent/ATE108662T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

This invention provides a purified polypeptide useful as an antimicrobial agent. This purified polypeptide has been derived from human granulocytes, and has a molecular weight of about 3,700 daltons and the N-terminal amino acid sequence val-cys-ser-cys-arg-leu-val-phe-cys-arg-arg-thr-glu- leu-arg-val-gly-asn-cys-leu-ile-gly-gly-val-ser-phe-thr-try-cys-thr-ar g-val. This invention also provides methods for producing this polypeptide, pharmaceutical compositions containing the polypeptide, and uses thereof.
AT89907461T 1988-05-26 1989-05-26 ANTIMICROBIAL PEPTIDES, COMPOSITIONS CONTAINING SAME AND USES THEREOF. ATE108662T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/199,206 US5032574A (en) 1988-05-26 1988-05-26 Novel antimicrobial peptide

Publications (1)

Publication Number Publication Date
ATE108662T1 true ATE108662T1 (en) 1994-08-15

Family

ID=22736639

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89907461T ATE108662T1 (en) 1988-05-26 1989-05-26 ANTIMICROBIAL PEPTIDES, COMPOSITIONS CONTAINING SAME AND USES THEREOF.

Country Status (8)

Country Link
US (1) US5032574A (en)
EP (1) EP0378641B1 (en)
JP (1) JP2795286B2 (en)
AT (1) ATE108662T1 (en)
AU (1) AU633832B2 (en)
CA (1) CA1340379C (en)
DE (1) DE68916932T2 (en)
WO (1) WO1989011291A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844072A (en) * 1992-05-26 1998-12-01 University Of California Antibiotic cryptdin peptides and methods of their use
US4304715A (en) * 1979-06-08 1981-12-08 Derek Hudson Enkephalin analogues
US5066792A (en) * 1987-09-04 1991-11-19 Board Of Regents University Of Texas Gene probe for detection of specific human leukemias
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
US5631007A (en) * 1990-03-12 1997-05-20 Ciba-Geigy Corporation Anti-pathogenically effective compositions comprising lytic peptides and hydrolytic enzymes
PH30997A (en) * 1990-03-12 1997-12-23 Ciba Geigy Antipathologenically effective compositions comprising lytic peptides and hydrolytic enzymes.
US5766897A (en) * 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
US5432270A (en) * 1990-10-25 1995-07-11 Zasloff; Michael A. DNA encoding tracheal antimicrobial peptides
US5202420A (en) * 1990-10-25 1993-04-13 The Children's Hospital Of Philadelphia Tracheal antimicrobial peptides, dna sequences and methods for the production and use thereof
US5912230A (en) * 1991-11-01 1999-06-15 Periodontix, Inc. Anti-fungal and anti-bacterial histatin-based peptides
US5631228A (en) * 1991-11-01 1997-05-20 Periodontix, Inc. Anti-fungal and anti-bacterial histatin-based peptides
US5646119A (en) * 1991-11-01 1997-07-08 Periodontix, Inc. D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents
US5885965A (en) * 1991-11-01 1999-03-23 Periodontix, Inc. Anti-fungal D-amino acid histatin-based peptides
US5486503A (en) * 1991-11-01 1996-01-23 The Trustees Of Boston University Anti-fungal histatin-based peptides
AU678362B2 (en) * 1992-05-26 1997-05-29 General Hospital Corporation, The Antibiotic cryptdin peptides and methods of their use
US5422424A (en) * 1992-05-26 1995-06-06 The Regents Of The University Of California Antibiotic cryptdin peptides and methods of their use
US6214789B1 (en) * 1993-03-12 2001-04-10 Xoma Corporation Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
US5804558A (en) * 1993-07-20 1998-09-08 University Of California Protegrins
US6653442B1 (en) 1993-07-20 2003-11-25 Intrabiotics Pharmaceuticals, Inc. Protegrins
US5693486A (en) * 1993-07-20 1997-12-02 Intrabiotics DNA sequences encoding protegrins and protegrin analogs and their use in recombinant methods of producing protegrins
US5708145A (en) * 1993-07-20 1998-01-13 University Of California Immunglobulins reactive with protegrins
DE69424680T2 (en) * 1993-10-25 2000-09-28 The Liposome Co.,Inc. LIPOSOMAL DEFENSINE
US6025326A (en) * 1995-07-07 2000-02-15 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of oral mucositis
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins
US5916872A (en) * 1996-07-24 1999-06-29 Intrabiotics Pharmaceuticals, Inc. Cyclic peptides having broad spectrum antimicrobial activity
FR2767832B1 (en) 1997-08-29 2001-08-10 Genset Sa DEFENSINE DEFENSINE POLYPEPTIDE DEF-X, GENOMIC DNA AND CDNA, COMPOSITION CONTAINING THEM AND APPLICATIONS TO DIAGNOSIS AND THERAPEUTIC TREATMENT
US6531573B1 (en) 1997-12-18 2003-03-11 Trustees Of Boston University Antifungal and antibacterial peptides
WO2000078793A2 (en) 1999-06-22 2000-12-28 University Of Louisville Research Foundation, Inc. Antimicrobial agents
GB0300597D0 (en) 2003-01-10 2003-02-12 Microbiological Res Authority Phage biofilms
CA2533352C (en) 2003-07-23 2016-01-19 Biocontrol Limited Bacteriophage-containing therapeutic agents
GB0704553D0 (en) 2007-03-09 2007-04-18 Harper David R Beneficial effects of bacteriophage treatments
US20100150985A1 (en) * 2008-04-24 2010-06-17 George Just Dental Implant, Endodontic Instrument, and Dental Filling Material Coated with a Peptide-Based Antimicrobial and Methods of Using and Making the Same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705777A (en) * 1985-02-25 1987-11-10 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity

Also Published As

Publication number Publication date
JPH02504396A (en) 1990-12-13
DE68916932T2 (en) 1994-11-03
AU633832B2 (en) 1993-02-11
AU3778289A (en) 1989-12-12
DE68916932D1 (en) 1994-08-25
WO1989011291A1 (en) 1989-11-30
CA1340379C (en) 1999-02-02
EP0378641A4 (en) 1990-12-12
US5032574A (en) 1991-07-16
EP0378641A1 (en) 1990-07-25
EP0378641B1 (en) 1994-07-20
JP2795286B2 (en) 1998-09-10

Similar Documents

Publication Publication Date Title
DE68916932D1 (en) ANTIMICROBIAL PEPTIDES, COMPOSITIONS CONTAINING THEM AND USES THEREOF.
PT792287E (en) PEPTIDICAL ANALOGS OF HUMAN MYELIN BASIC PROTEIN
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
DE69627704D1 (en) Protegrine
PT73161A (en) PROCESS FOR THE PREPARATION OF N- (VYNBLASTINOYL-23) AMINO-ACIDS AND PEPTIDES DERIVATIVES AND ITS THERAPEUTIC APPLICATION
MD1443G2 (en) Copolymer-1 fraction, process for preparation thereof and compositions on base thereof for cerebrospinal sclerosis treatment
DE59007517D1 (en) NEW PROTEINS WITH TNF-INHIBITING EFFECT AND THEIR PRODUCTION.
CA2142007A1 (en) Immunomodulatory peptides
ATE209215T1 (en) PROTEGRINS
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
EP1088890A3 (en) Recombinant BPI proteins, uses of BPI proteins, and methods of preparing same
MX9703642A (en) Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein.
HUT69169A (en) T-cell-suppressive peptide fragments of human myelin basic protein (hmbp) and pharmaceutical compositions containing them
DE69820449D1 (en) T CELL MEMBRANE PROTEIN (TIRC7), DERIVED PEPTIDES AND ANTIBODIES AND THEIR USE
FI941860A0 (en) Synthetic peptide specificity of antimyelin base protein from central nervous system colonic cerebrospinal fluid
BR0312889A (en) Pegged t20 polypeptide
NZ235497A (en) Peptides (possibly related to hirudin) and pharmaceutical compositions for reducing blood coagulation
HUT52117A (en) Process for producing amblyommin and process for producing pharmaceutical compositions comprising such compound as active ingredient
DE69002881D1 (en) Peptides and their use.
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
ATE183652T1 (en) SYNTHETIC PEPTIDES FOR THE TREATMENT OF MYASTHENIA GRAVIS
EP0723016A3 (en) Activating factor of leukocytes
KR920700224A (en) New bioactive peptide and calcium metabolism modulator containing it as an active ingredient
ATE27822T1 (en) HEXAPEPTIDE, PROCESSES FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF.
GEP19981435B (en) Peptides with Organo-Protective Activity, Pharmaceutical Composition and the Use Thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee